4.7 Article

Downregulation of transcription factor SOX2 in cancer stem cells suppresses growth and metastasis of lung cancer

期刊

BRITISH JOURNAL OF CANCER
卷 104, 期 9, 页码 1410-1417

出版社

NATURE PUBLISHING GROUP
DOI: 10.1038/bjc.2011.94

关键词

cancer stem cells; side population; non-small cell lung tumour cells; transcription factor; SOX2; Hoechst 33342 dye

类别

资金

  1. National Natural Science Foundation of China (NSFC) [30671938, 81071711, 91029734]
  2. NIH [CA 115751]
  3. EMD Serono Research Center [SFP 1645]
  4. [30830096]
  5. [2007CB914804]
  6. [09ZCZDSF04000]

向作者/读者索取更多资源

BACKGROUND: The cancer stem cell hypothesis suggests that neoplastic clones are maintained exclusively by a small subpopulation of cells, which have indefinite proliferation and differentiation potentials and give rise to phenotypically diverse cancer cells. Cancer stem cells have been isolated by their ability to efflux Hoechst 33342 dye and are referred to as the 'side population' (SP). METHODS AND RESULTS: The Hoechst efflux assay was used to isolate and characterize the SP from murine D121 lung carcinoma cells. Here, we demonstrated that D121-SP cells contain cancer stem cell characteristics, that is, upregulation of the transcription factors SOX2 and Oct 4 in D121-SP cells. In addition, the migration of D121-SP was decreased, and apoptosis of D121-SP was upregulated following knocking down of SOX2 in D121 cells. Importantly, downregulation of SOX2 in D121 cells markedly suppressed their metastatic potential in syngeneic mice. CONCLUSIONS: These results suggest that the SP is an enriched source of lung tumour cells with stem cell properties and that SOX2 has an important role in maintaining stem cell properties and functions that may be a potential target for effective lung cancer therapy. British Journal of Cancer (2011) 104, 1410-1417. doi:10.1038/bjc.2011.94 www.bjcancer.com Published online 5 April 2011 (C) 2011 Cancer Research UK

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据